Radio and PodcastRadio and PodcastLive Radio & Podcasts
The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells artwork
Science & Medicine

The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells

Oncotarget by Oncotarget Podcast

Mar 31, 202600:02:12Science & Medicine

BUFFALO, NY – March 31, 2026 – A new paper was in Volume 17 of Oncotarget on March 27, 2026, titled “The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells.” Led by Michael R. Booth, Lau...

About This Episode

The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells is an episode from Oncotarget by Oncotarget Podcast. BUFFALO, NY – March 31, 2026 – A new paper was in Volume 17 of Oncotarget on March 27, 2026, t...

Podcast

This episode belongs to Oncotarget.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Mar 31, 2026, 00:02:12 long, audio available.

Related Episodes

Continue listening to more episodes from Oncotarget.